These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3928983)

  • 21. Immunoperoxidase localization of factor VIII in angiosarcomas.
    Guarda LA; Ordonez NG; Smith JL; Hanssen G
    Arch Pathol Lab Med; 1982 Oct; 106(10):515-6. PubMed ID: 6812545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor VIII-related antigen and lymphatic collecting vessels.
    Svanholm H; Nielsen K; Hauge P
    Virchows Arch A Pathol Anat Histopathol; 1984; 404(3):224-8. PubMed ID: 6437061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
    Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
    Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some immunofluorescent observations on factor VIII/von Willebrand factor in dogs.
    Potter EV; Shaughnessy MA; Green D
    Thromb Haemost; 1980 Oct; 44(2):56-61. PubMed ID: 6779399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease.
    Schwarz HP; Schlokat U; Mitterer A; Váradi K; Gritsch H; Muchitsch EM; Auer W; Pichler L; Dorner F; Turecek PL
    Semin Thromb Hemost; 2002 Apr; 28(2):215-26. PubMed ID: 11992244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical significance of plasma factor VIII levels in renal disease.
    Previato G; Loschiavo C; Lupo A; Faraggiana T; Valvo E; Tessitore N; Oldrizzi L; Maschio G
    Clin Nephrol; 1981 Oct; 16(4):200-6. PubMed ID: 6794966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on molecular size distribution of factor VIII-related antigen in patients with Von Willebrand's disease and their parents].
    Mikami S; Nishino M; Yasui M; Okubo Y; Shima H; Fukui H
    Rinsho Ketsueki; 1982 Aug; 23(8):1198-204. PubMed ID: 6815349
    [No Abstract]   [Full Text] [Related]  

  • 31. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
    Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
    Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
    [No Abstract]   [Full Text] [Related]  

  • 32. Mondor's phlebitis of the penis: a study with factor VIII related antigen.
    Tanii T; Hamada T; Asai Y; Yorifuji T
    Acta Derm Venereol; 1984; 64(4):337-40. PubMed ID: 6209894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Culture and characterization of bovine mesenteric lymphatic endothelium.
    Jones BE; Yong LC
    In Vitro Cell Dev Biol; 1987 Oct; 23(10):698-706. PubMed ID: 3117764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Destruction of factor VIII procoagulant activity in tissue culture media.
    Stead NW; McKee PA
    Blood; 1978 Aug; 52(2):408-24. PubMed ID: 307419
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor VIII related antigen: an improved enzyme immunoassay.
    Short PE; Williams CE; Picken AM; Hill FG
    Med Lab Sci; 1982 Oct; 39(4):351-5. PubMed ID: 6817017
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions.
    Ordóñez NG; Batsakis JG
    Arch Pathol Lab Med; 1984 Feb; 108(2):129-32. PubMed ID: 6198997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactivity of small molecular forms of human factor VIII/von Willebrand factor with botrocetin and anti-factor VIII-coated latex particles.
    Furlan M; Perret BA; Beck EA
    Thromb Haemost; 1985 Aug; 54(2):463-5. PubMed ID: 3936216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Factor VIII:C and factor VIII:Ag in liver diseases].
    Procházka J; Hauftová D; Fischerová E; Smrcková H
    Cesk Gastroenterol Vyz; 1983 Nov; 37(6-7):364-72. PubMed ID: 6418392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.